Target Healthcare REIT PLC

Target Healthcare REIT PLC maintains a fully diluted share count of 620.24 million, with no difference between basic and diluted shares outstanding, indicating no dilution risk from share-based compensation or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

Profitability metrics are not available in the current valuation snapshot, and no industry-specific preferred metrics are provided for comparison. The company's returns on invested capital or operating margins are not disclosed, limiting the ability to benchmark against industry peers.

The company's revenue is concentrated in the UK healthcare property market, with no disclosed segment or geographic diversification. This concentration increases exposure to local regulatory changes, tenant defaults, or shifts in healthcare demand.

Growth trajectory is not quantified in the current outlook, as no numeric deltas or revenue history are provided. Analysts have assigned a mean price target of 108.67 GBP, with a median of 110.00 GBP, suggesting a generally positive sentiment, though the mean recommendation of 2.00 (on a 1–5 scale) indicates a neutral stance.

Risk factors include the inability to assess liquidity risk and the lack of disclosed capital structure details. The company has a low dilution potential, as no dilutive instruments are currently outstanding. Recent filings do not indicate any material events or earnings calls that would alter the current risk profile.

No recent events, such as earnings calls, regulatory filings, or major business developments, are disclosed in the available data. The company's operations appear stable, but the absence of recent disclosures limits visibility into strategic shifts or operational performance.

Revenue £72.9M, +4,9% YoY; Operating income −15,1% YoY.

• ▍Revenue £72.9M, +4,9% YoY
• ▍Operating income −15,1% YoY
• ▍Net income −16,7% YoY
• ▍Net margin 83.4%

Revenue £69.6M, +2,7% YoY; Operating income +2 274,4% YoY.

• ▍Revenue £69.6M, +2,7% YoY
• ▍Operating income +2 274,4% YoY
• ▍Net income +1 211,1% YoY
• ▍Net margin 105.0%

Revenue £67.7M, +6,1% YoY; Operating income −93,6% YoY.

• ▍Revenue £67.7M, +6,1% YoY
• ▍Operating income −93,6% YoY
• ▍Net income −113,4% YoY
• ▍Net margin -9.7%

Revenue £63.9M, +27,8% YoY; Operating income +14,4% YoY.

• ▍Revenue £63.9M, +27,8% YoY
• ▍Operating income +14,4% YoY
• ▍Net income +11,9% YoY
• ▍Net margin 76.9%

Revenue £50.0M; Operating income £48.7M.

• ▍Revenue £50.0M
• ▍Operating income £48.7M
• ▍Net margin 87.8%